T, C., YL, L., HN, Q., CY, L., F, W., JB, L., & JN, L. (2025). Metformin reduces the risk of frailty: Evidence from a Mendelian randomization study. Diabetology & metabolic syndrome, 17(1), 239. https://doi.org/10.1186/s13098-025-01825-2
Chicago Style (17th ed.) CitationT, Chen, Liu YL, Qiu HN, Lin CY, Wu F, Li JB, and Lin JN. "Metformin Reduces the Risk of Frailty: Evidence from a Mendelian Randomization Study." Diabetology & Metabolic Syndrome 17, no. 1 (2025): 239. https://doi.org/10.1186/s13098-025-01825-2.
MLA (9th ed.) CitationT, Chen, et al. "Metformin Reduces the Risk of Frailty: Evidence from a Mendelian Randomization Study." Diabetology & Metabolic Syndrome, vol. 17, no. 1, 2025, p. 239, https://doi.org/10.1186/s13098-025-01825-2.